Search

Author/Creator Spuls, Phyllis I

2. Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs). Issue 3 (4th March 2023)

Authors:
de Boer, Merel; Gosselt, Helen R; Jansen, Jurriaan; van Doorn, Martijn B.A; Hoentjen, Frank; Nurmohamed, Michael T; Spuls, Phyllis I; Tas, Sander W; Vonkeman, Harald E; Jessurun, Naomi T
Journal:
Expert opinion on drug safety
Issue:
Volume 22:Issue 3(2023)
Page Start:
195
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases. Issue 12 (5th September 2022)

Authors:
Stalman, Eileen W; Wieske, Luuk; van Dam, Koos P J; Kummer, Laura Y; van Kempen, Zoé L E; Killestein, Joep; Volkers, Adriaan G; Tas, Sander W; Boekel, Laura; Wolbink, Gertjan J; Van der Kooi, Anneke J; Raaphorst, Joost; Löwenberg, Mark; Takkenberg, R Bart; D'Haens, Geert R A M; Spuls, Phyllis I; ...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 81:Issue 12(2022)
Page Start:
1757
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies. (June 2022)

Authors:
Boekel, Laura; Stalman, Eileen W; Wieske, Luuk; Hooijberg, Femke; van Dam, Koos P J; Besten, Yaëlle R; Kummer, Laura Y L; Steenhuis, Maurice; van Kempen, Zoé L E; Killestein, Joep; Volkers, Adriaan G; Tas, Sander W; van der Kooi, Anneke J; Raaphorst, Joost; Löwenberg, Mark; Takkenberg, R Bart; D'...
Journal:
Lancet
Issue:
Volume 4:Number 6(2022)
Page Start:
e417
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study. (May 2022)

Authors:
Wieske, Luuk; van Dam, Koos P J; Steenhuis, Maurice; Stalman, Eileen W; Kummer, Laura Y L; van Kempen, Zoé L E; Killestein, Joep; Volkers, Adriaan G; Tas, Sander W; Boekel, Laura; Wolbink, Gerrit J; van der Kooi, Anneke J; Raaphorst, Joost; Löwenberg, Mark; Takkenberg, R Bart; D'Haens, Geert R A ...
Journal:
Lancet
Issue:
Volume 4:Number 5(2022)
Page Start:
e338
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Patients' perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes. Issue 12 (2nd December 2021)

Authors:
Kosse, Leanne J; Weits, Gerda; Vonkeman, Harald E; Tas, Sander W; Hoentjen, Frank; Van Doorn, Martijn BA; Spuls, Phyllis I; D'Haens, Geert R; Nurmohamed, Michael T; van Puijenbroek, Eugène P; Van Den Bemt, Bart JF; Jessurun, Naomi T
Journal:
Expert opinion on drug safety
Issue:
Volume 20:Issue 12(2021)
Page Start:
1565
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis. Issue 8 (29th August 2018)

Authors:
Drucker, Aaron Mark; Ellis, Alexandra; Jabbar-Lopez, Zarif; Yiu, Zenas Z N; Arents, Bernd W M; Burton, Tim; Spuls, Phyllis I; Küster, Denise; Schmitt, Jochen; Flohr, Carsten
Journal:
BMJ open
Issue:
Volume 8:Issue 8(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗